Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg
Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg
Active, not recruiting · NCT05569239 · Registry updated 2025-12-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Active, not recruiting | Phase 2 | 2025-12-17 | NCT05569239 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Osivax | 1 |
16 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| FI-14 | Kokkola | Finland | 1 |
| Site BE-01 | Ghent | Belgium | 1 |
| Site BE-02 | Antwerp | Belgium | 1 |
| Site BE-03 | Antwerp | Belgium | 1 |
| Site BE-04 | Mechelen | Belgium | 1 |
| Site DE-16 | München | Germany | 1 |
| Site FI-08 | Helsinki | Finland | 1 |
| Site FI-09 | Tampere | Finland | 1 |
| Site FI-10 | Turku | Finland | 1 |
| Site FI-11 | Oulu | Finland | 1 |
| Site FI-12 | Espoo | Finland | 1 |
| Site FI-13 | Jarvenpaa | Finland | 1 |
| Site FI-15 | Seinäjoki | Finland | 1 |
| Site FR-05 | Lyon | France | 1 |
| Site FR-06 | Rennes | France | 1 |
| Site FR-07 | Paris | France | 1 |